A comparison of the TempO-Seq and Affymetrix microarray platform using RTqPCR validation

Abstract Next-generation risk assessment relies on mechanistic data from new approach methods, including transcriptome data. Various technologies, such as high-throughput targeted sequencing methods and microarray technologies based on hybridization with complementary probes, are used to determine d...

Full description

Bibliographic Details
Published in:BMC Genomics
Main Authors: Matthias M. Wehr, Stella Marie Reamon-Buettner, Detlef Ritter, Jan Knebel, Monika Niehof, Sylvia E. Escher
Format: Article
Language:English
Published: BMC 2024-07-01
Subjects:
Online Access:https://doi.org/10.1186/s12864-024-10586-7